In a report released today, Lance Vitanza from TD Cowen reiterated a Buy rating on Compass Diversified Holdings (CODI – Research Report), with ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Gautam Khanna, analyst at TD Cowen, shares his outlook for Boeing and says it will take "a number of years" before the ...

The first quarter edition of the TD Cowen/AFS Freight Index, which was recently released by New York-based investment firm TD ...

TD Cowen downgraded Paycor HCM (PYCR) to Hold from Buy with a price target of $22.50, up from $22, following the takeover offer from Paychex ...

Blue Owl Capital Inc (OWL) stock saw a modest uptick, ending the day at $23.4 which represents a slight increase of $0.49 or 2.14% from the prior close of $22.91. The stock opened at $23.15 and ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

Broadcom Inc (AVGO) stock saw a modest uptick, ending the day at $229.41 which represents a slight increase of $1.41 or 0.62% from the prior close of $228. The stock opened at $235.22 and touched a ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...